New EDPB Opinion: Vendors in Clinical Trials
The European Data Protection Board (EDPB) recently issued Opinion 24/2024, focusing on a critical aspect of data protection compliance:...
The European Data Protection Board (EDPB) recently issued Opinion 24/2024, focusing on a critical aspect of data protection compliance:...
Digital Health Technologies (DHTs) use in clinical research is no longer a futuristic concept—it’s quickly becoming the norm. Recognizing...
Globalization has long been seen as a cornerstone of growth for the big pharma industry, enabling companies to expand...
As the clinical trial landscape evolves under the EU Clinical Trials Regulation (CTR), transparency and privacy have become central...
In the rapidly evolving landscape of health data regulation, the European Health Data Space (EHDS) initiative marks a transformative...
The U.S. FDA issued a draft guidance document, “Processes and Practices Applicable to Bioresearch Monitoring (BIMO) Inspections,” to streamline...
The landscape of clinical trials is experiencing a paradigm shift with the integration of Real-World Data (RWD). Traditionally conducted...
In the complex and highly regulated environment of clinical trials, the Trial Master File (TMF) is a foundational tool...
Patient recruitment and retention are among the most critical challenges in the fast-evolving world of clinical trials. In 2000,...
Artificial Intelligence (AI) is playing an increasingly significant role in scientific research and development (R&D), particularly within the biopharmaceutical...